$34.20
+0.28 (+0.83%)
Open$34.01
Previous Close$33.92
Day High$34.23
Day Low$33.75
52W High$54.85
52W Low$28.54
Volume—
Avg Volume532.8K
Market Cap1.24B
P/E Ratio—
EPS$-1.00
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-28.0% upside
Current
$34.20
$34.20
Target
$24.64
$24.64
$15.17
$24.64 avg
$37.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 281.08M | 193.33M | 753.50M |
| Net Income | -5,304,850 | -3,283,833 | 117.60M |
| Profit Margin | -1.9% | -1.8% | 15.6% |
| EBITDA | 25.48M | 16.65M | 185.25M |
| Free Cash Flow | — | — | 80.89M |
| Rev Growth | +45.4% | +45.4% | +23.8% |
| Debt/Equity | 4.64 | 4.64 | 0.62 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |